Idex Corp /De/ (IEX) Stock Price & Analysis
Idex Corp /De/ (IEX) rose 0.47% to USD 223.27 as of July 25, 2026 at 01:44 UTC, according to Nexqual real-time market data.
IEX last closed at USD 222.22; the session ranged USD 221.73–224.7 on volume of 469,374 shares. Market capitalization is $16.53B, with a 52-week range of USD 157.25–231.7 (NYQ). Source: Nexqual, July 25, 2026 at 01:44 UTC.
Key Statistics (as of July 25, 2026 at 01:44 UTC)
| Price | USD 223.27 |
|---|---|
| Change | ▲ 0.47% (up) |
| Previous Close | USD 222.22 |
| Open | USD 222.92 |
| Day Range | USD 221.73 – 224.7 |
| 52-Week Range | USD 157.25 – 231.7 |
| Volume | 469,374 shares |
| Market Cap | $16.53B |
| Exchange | NYQ |
Technical Analysis (IEX)
Nexqual's technical model rates IEX "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:44 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.51 (neutral) |
| vs SMA50 | Above (USD 218.55) |
| MACD | 0.92 (positive) |
Analyst Ratings (IEX)
Wall Street analysts rate IEX "Buy" based on 14 analysts, with a mean price target of USD 239.43 (range USD 210–261), per Nexqual as of July 25, 2026 at 01:44 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 14 |
| Mean Target | USD 239.43 |
| High Target | USD 261 |
| Low Target | USD 210 |
| Buy / Hold / Sell | 8 / 7 / 0 |
Earnings (IEX)
| Next Earnings Date | 2026-07-29 |
|---|---|
| EPS Estimate | USD 2.11 |
| Revenue Estimate | $905.37M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2 vs est 1.77 ▲ beat |
| 2025-12-31 | USD 2.1 vs est 2.04 ▲ beat |
| 2025-09-30 | USD 2.03 vs est 1.93 ▲ beat |
| 2025-06-30 | USD 2.07 vs est 1.99 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Financials & Fundamentals (IEX)
| Total Revenue | $3.53B |
|---|---|
| Revenue Growth (YoY) | +8.90% |
| Gross Margin | +44.44% |
| Operating Margin | +19.89% |
| Profit Margin | +14.38% |
| ROE | +12.75% |
| Debt / Equity | 46.92 |
| Current Ratio | 3.39 |
| Total Cash | $586.20M |
| Total Debt | $1.90B |
| Free Cash Flow | $525.02M |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Financial Health Score (IEX)
Nexqual rates Idex Corp /De/'s overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:44 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 20% |
| Balance Sheet | Strong — $586M cash vs $1.90B debt |
| Cash Flow | Strong — FCF $525M, 15% margin |
| Efficiency | Mixed — ROE 13%, ROA 6.8% |
Ownership (IEX)
| Insider Ownership | +0.22% |
|---|---|
| Institutional Ownership | +105.89% |
| Shares Outstanding | 74.02M |
| Float | 73.81M |
| Short % of Float | +3.63% |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
Leadership (IEX)
Idex Corp /De/ is led by Eric D. Ashleman (age 58), CEO, President & Director, per Nexqual as of July 25, 2026 at 01:44 UTC.
| CEO, President & Director | Eric D. Ashleman (age 58) |
|---|---|
| Vice President of Corporate Development | Akhil Mahendra (age 43) |
| Senior VP & CFO | Sean M. Gillen (age 39) |
| Vice President of Investor Relations | James Giannakouros C.F.A. |
| Vice President of Global Communications | Mark Spencer |
Major Backers & Investors (IEX)
Notable institutional backers of Idex Corp /De/ include Primecap Management Company, Morgan Stanley, Millennium Management, according to Nexqual as of July 25, 2026 at 01:44 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Primecap Management Company | 4.46% |
| Morgan Stanley | 4.19% |
| Millennium Management | 2.7% |
| Nordea Investment Management AB | 2.53% |
| Wellington Management | 2.35% |
| Eaton Vance Growth Trust-Eaton Vance Atlanta Capital SMID-Cap Fund | 1.49% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 24.49% |
| BlackRock | 9% |
| State Street | 4.33% |
| Geode Capital | 2.82% |
Source: Nexqual, July 25, 2026 at 01:44 UTC.
From Idex Corp /De/'s Latest SEC 10-K Filing (filed 2026-02-19)
Key Strengths & Strategy (as disclosed to the SEC)
- IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally.
- It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP).
- The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and custom mechanical and shaft seals.
- This segment also offers engineered hygienic mixers and valves, biocompatible medical devices and implantable products, air compressors and blowers, optical components and coatings, ultra-precision diamond tools, and laboratory and commercial equipment, as well as precision photonic solutions, technical ceramics, hermetic sealing products, porous material structures, and flow control solutions.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AME | AMETEK, Inc. | USD 241.97 | ▲ 2.06% |
| ALLE | Allegion plc | USD 153.36 | ▲ 9.58% |
| FTV | Fortive Corporation | USD 62.31 | ▲ 3.42% |
| MTD | Mettler-Toledo International, I | USD 1,327.18 | ▲ 3.21% |
| NDSN | Nordson Corporation | USD 295.77 | ▲ 1.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:44 UTC. This page is informational and not investment advice.